<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb1105">
 <label>221</label>
 <element-citation publication-type="journal" id="rf1095">
  <person-group person-group-type="author">
   <name>
    <surname>Alberti</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Beretta</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Piatti</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Karantzoulis</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Piatti</surname>
    <given-names>M.L.</given-names>
   </name>
   <name>
    <surname>Santoro</surname>
    <given-names>P.</given-names>
   </name>
  </person-group>
  <article-title>Guillain-Barr√© syndrome related to COVID-19 infection</article-title>
  <source>Neurol Neuroimmunol Neuroinflamm.</source>
  <volume>7</volume>
  <issue>4</issue>
  <year>2020 Apr 29</year>
  <fpage>e741</fpage>
  <pub-id pub-id-type="pmid">32350026</pub-id>
 </element-citation>
</ref>
